Seeking Alpha

ACETO unit buys generic drug distributor

  • Rising Pharmaceuticals, a wholly-owned subsidiary of ACETO Corp. (ACET), signs a definitive purchase agreement to acquire PACT Pharmaceuticals, a marketer and distributor of generic prescription and OTC products.
  • The cash-and-stock deal is worth $100M. The initial payment is $80M in cash and $5M in ACETO stock. Earn-outs total $15M based on achieving certain performance-based targets over the next three years.
  • The acquisition will enable the firm to expand further into the finished dosing drug business.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs